Apogee Therapeutics Inc.

NASDAQ: APGE
Share price (12/23/24): $47.50
Market cap (12/23/24): $2.779 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

McKenna Mark C.

Dambkowski Carl

Dambkowski Carl

Henderson Michael Thomas

News Filter

Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, Its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions

Highlights Progress and Best-In-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day

Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results

Announces Results Up to 9 Months From Phase 1 Trial of APG777, Its Novel Half-Life Extended Anti-Il-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases

Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, Its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC